CJC-1295 DAC dosage protocols leverage this long-acting growth hormone-releasing hormone (GHRH) analog’s unique albumin-binding technology, which extends its half-life to approximately 6–8 days[1][2]. By stimulating pulsatile growth hormone (GH) release while preserving natural GH rhythms, CJC-1295 DAC can elevate GH levels 2–10 fold and IGF-1 levels 1.5–3 fold in human studies[3]. Benefits may include enhanced muscle growth and recovery, improved fat metabolism, better sleep quality, and anti-aging effects through sustained GH/IGF-1 axis activation[4][5]. This educational protocol presents a once-weekly subcutaneous approach using a practical dilution for clear insulin-syringe measurements.
- 재구성: 1.0 mL의 세균 억제수를 추가하십시오 → 2.0 mg/mL (2,000 mcg/mL) 농도.
- 일반적인 주간 용량: 2,000 mcg (2 mg) 주 1회 - 주사당 전체 바이알.
- 간편한 측정: 2.0 mg/mL에서 1 단위 = 0.01 mL = U-100 인슐린 주사기에 20 mcg; 전체 용량 = 100 단위 (1.00 mL).
- 저장: 동결 건조: −20 °C (−4 °F)에서 냉동; 재구성 후 2–8 °C (35.6–46.4 °F)에서 냉장; 동결-해동 사이클을 피하십시오.
